A 100% subsidiary of BSV, BSV BioSciences Inc is a research and drug development company dedicated to the early stage development of recombinant molecules.. Utilizing in-house molecular biology and recombinant expression capabilities, BSV Biosciences has developed multiple cell lines for various products. Specifically, the company has developed cell lines and lab scale processes for two biosimilar products and two "first-in the world" products. These products are in various stages of clinical development and commercialization.
A 100% subsidiary of BSV, BSV BioSciences GmBH is engaged in the research, development and manufacturing of therapeutic proteins derived from natural sources. It develops state of the art isolation and purification methods for bulk pharmaceutical actives, as well as finished formulation.BSV Bio also has a state of the art biological API plant in Aachen, Germany. The plant manufactures urinary derived gonadotropins and highly purified gonadotropins.
Zydus BSV Pharma Pvt. Ltd., founded in 2005 is a 50:50 joint venture company of BSV, and Zydus Cadila, a global healthcare company. The JV was formed for the further development, manufacturing and commercialization of patented anti cancer formulation developed and patented by BSV. Zydus BSV also offers Contract Manufacturing capabilities based on its modern facility and experience in the Oncology injectable product manufacturing area. Zydus BSV's finished dosage manufacturing plant is located at the pharmaceutical specific Special Economic Zone - Pharmez, strategically located in the pharma corridor of India, near Ahmedabad.